Protecting the Filters: Kidney Health and Management in NPS
At a Glance
Nail-Patella Syndrome (NPS) can affect the kidneys, causing protein or blood to leak into the urine. While most patients won't experience kidney failure, lifelong annual monitoring is essential. Avoiding NSAIDs and using medications like ACE inhibitors can help protect kidney function over time.
Kidney health is one of the most critical aspects of managing Nail-Patella Syndrome (NPS). While the skeletal changes are often the first thing people notice, the way NPS affects the kidneys—known as NPS nephropathy—requires lifelong, proactive monitoring to ensure long-term health and safety.
The Kidney’s Filtering System
To understand how NPS affects the kidneys, it helps to think of the kidney as a sophisticated filtration plant.
- Podocytes: These are specialized cells that act as “gatekeepers” in the kidney’s filters. The LMX1B gene provides the instructions to build the internal support structure (the actin cytoskeleton) of these cells [1].
- The Filter (GBM): The glomerular basement membrane (GBM) is the actual mesh that keeps important things like protein in the blood while letting waste pass through.
In NPS, the LMX1B mutation causes these filters to develop incorrectly. Under a microscope, they may appear abnormally thickened or have a “moth-eaten” look due to disorganized collagen [2]. This allows substances that should stay in the blood to “leak” into the urine.
Key Signs: Proteinuria and Hematuria
Because you cannot feel kidney changes in their early stages, doctors look for two specific markers in the urine:
- Proteinuria: This is the presence of excess protein in the urine [3]. It is often the first sign that the kidney’s filters are under stress. If the level of protein is high, the urine may appear foamy.
- Hematuria: This is the presence of blood in the urine [3]. It may be visible to the eye (making urine look pink or tea-colored) or only detectable under a microscope.
Risk and Progression
While approximately 30% to 50% of people with NPS will show some signs of kidney involvement, the majority will not experience total kidney failure [4].
- End-Stage Renal Disease (ESRD): This is a serious stage where the kidneys can no longer function on their own. About 5% to 15% of all people with NPS progress to this stage [5][6].
- Typical Age of Progression: While monitoring must begin in childhood, ESRD typically occurs in adulthood (most commonly in the 3rd to 5th decades of life) [5][6].
Pregnancy and Kidney Health
For individuals with NPS who are planning a family, it is important to know that pregnancy can place significant extra strain on the kidneys. High-risk monitoring is strongly recommended during pregnancy to track kidney function and blood pressure safely.
The Standard of Care: Protection and Monitoring
The goal of NPS kidney management is early detection and protection.
Protecting the Filters
If proteinuria is detected, doctors often prescribe medications called ACE inhibitors or ARBs [5]. These medications lower the pressure inside the kidney’s filtering units, which helps reduce the amount of protein leaking out and slows down the progression of the disease [7].
Note: ACE inhibitors and ARBs are contraindicated during pregnancy (teratogenic). Discuss alternatives with your doctor if you are planning to become pregnant.
Critical Safety Warning: Pain Management
Given the frequent joint pain associated with NPS, many patients reach for over-the-counter pain medications like NSAIDs (ibuprofen, naproxen, Advil, Aleve). NSAIDs can severely damage compromised kidneys and trigger kidney failure. Always consult your nephrologist before taking any over-the-counter pain medications.
Annual Monitoring Checklist
Every person with NPS, starting from birth, should have the following checks performed at least once a year [8]:
- Urinalysis: A simple urine test to check for protein and blood.
- Blood Pressure Check: High blood pressure can both cause and be a sign of kidney stress. Keeping blood pressure in a healthy range is essential for protecting the kidneys.
- Protein-to-Creatinine Ratio: If protein is found, this more specific test helps determine exactly how much is being lost.
By catching kidney changes early, the medical team can use protective treatments to maintain kidney function for as long as possible.
Common questions in this guide
How does Nail-Patella Syndrome affect the kidneys?
What are the early signs of kidney issues in NPS?
How often should kidney function be checked in people with NPS?
Can I take NSAIDs for joint pain if I have Nail-Patella Syndrome?
What treatments are used to protect the kidneys in NPS?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Has my child shown any signs of proteinuria or hematuria in their recent tests?
- 2.At what level of protein in the urine would you recommend starting an ACE inhibitor or ARB?
- 3.How often should we be checking blood pressure at home versus in the clinic?
- 4.If my child's kidney function changes, what are the next steps for a referral to a pediatric nephrologist?
- 5.What safe pain management options do you recommend that will not harm the kidneys?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (8)
- 1
Nail-patella syndrome.
Witzgall R
Pflugers Archiv : European journal of physiology 2017; (469(7-8)):927-936 doi:10.1007/s00424-017-2013-z.
PMID: 28681095 - 2
LMX1B-associated nephropathy that showed myelin figures on electron microscopy.
Shimohata H, Miyake Y, Yoshida Y, et al.
CEN case reports 2021; (10(4)):588-591 doi:10.1007/s13730-021-00612-y.
PMID: 34076843 - 3
Myelin bodies in LMX1B-associated nephropathy: potential for misdiagnosis.
Lei L, Oh G, Sutherland S, et al.
Pediatric nephrology (Berlin, Germany) 2020; (35(9)):1647-1657 doi:10.1007/s00467-020-04564-w.
PMID: 32356190 - 4
AJKD Atlas of Renal Pathology: Nail-Patella Syndrome-Associated Nephropathy.
Najafian B, Smith K, Lusco MA, et al.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2017; (70(4)):e19-e20 doi:10.1053/j.ajkd.2017.08.001.
PMID: 28941488 - 5
Clinical and genetic characterization of nephropathy in patients with nail-patella syndrome.
Harita Y, Urae S, Akashio R, et al.
European journal of human genetics : EJHG 2020; (28(10)):1414-1421 doi:10.1038/s41431-020-0655-3.
PMID: 32457516 - 6
Nail-Patella syndrome with early onset end-stage renal disease in a child with a novel heterozygous missense mutation in the LMX1B homeodomain: A case report.
Carinelli S, Blanco OA, Perdomo-Ramirez A, Claverie-Martin F
Biomedical reports 2020; (13(5)):49 doi:10.3892/br.2020.1356.
PMID: 32963778 - 7
Angiotensin-converting enzyme inhibitors in patients with Alport syndrome: can all patients benefit?
Rheault MN
Kidney international 2020; (98(6)):1400-1402 doi:10.1016/j.kint.2020.07.011.
PMID: 33276866 - 8
Letter to the editor in reponse to Louboutin, Wascher, and Neyret in management of patellar problems in skeletally mature patients with nail-patella syndrome. KSSTA 2017 Oct;25(10):3012-3016. https://doi.org/10.1007/s00167-016-4044-y. Epub 2016 Feb 12.
Koëter S, Tigchelaar S, Bongers E
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 2021; (29(3)):1006-1007 doi:10.1007/s00167-018-4911-9.
PMID: 29594322
This page provides educational information about kidney health and management in Nail-Patella Syndrome. It does not replace professional medical advice, diagnosis, or treatment from your nephrologist.
Get notified when new evidence is published on Nail-patella syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.